105 related articles for article (PubMed ID: 29687467)
1. Estimating lead-time bias in lung cancer diagnosis of patients with previous cancers.
Ge Z; Heitjan DF; Gerber DE; Xuan L; Pruitt SL
Stat Med; 2018 Jul; 37(16):2516-2529. PubMed ID: 29687467
[TBL] [Abstract][Full Text] [Related]
2. The effect of statins on survival in patients with stage IV lung cancer.
Lin JJ; Ezer N; Sigel K; Mhango G; Wisnivesky JP
Lung Cancer; 2016 Sep; 99():137-42. PubMed ID: 27565929
[TBL] [Abstract][Full Text] [Related]
3. Thermal ablation matches sublobar resection outcomes in older patients with early-stage non-small cell lung cancer.
Kwan SW; Mortell KE; Talenfeld AD; Brunner MC
J Vasc Interv Radiol; 2014 Jan; 25(1):1-9.e1. PubMed ID: 24365502
[TBL] [Abstract][Full Text] [Related]
4. Effect of prior cancer on outcomes in advanced lung cancer: implications for clinical trial eligibility and accrual.
Laccetti AL; Pruitt SL; Xuan L; Halm EA; Gerber DE
J Natl Cancer Inst; 2015 Apr; 107(4):. PubMed ID: 25667420
[TBL] [Abstract][Full Text] [Related]
5. Survival associated with chronic obstructive pulmonary disease among SEER-Medicare beneficiaries with non-small-cell lung cancer.
Shah S; Blanchette CM; Coyle JC; Kowalkowski M; Arthur ST; Howden R
Int J Chron Obstruct Pulmon Dis; 2019; 14():893-903. PubMed ID: 31118599
[No Abstract] [Full Text] [Related]
6. Pulmonologist involvement, stage-specific treatment, and survival in adults with non-small cell lung cancer and chronic obstructive pulmonary disease.
Deepak JA; Ng X; Feliciano J; Mao L; Davidoff AJ
Ann Am Thorac Soc; 2015 May; 12(5):742-51. PubMed ID: 25760983
[TBL] [Abstract][Full Text] [Related]
7. Five-year survival does not equal cure in non-small cell lung cancer: a Surveillance, Epidemiology, and End Results-based analysis of variables affecting 10- to 18-year survival.
Hubbard MO; Fu P; Margevicius S; Dowlati A; Linden PA
J Thorac Cardiovasc Surg; 2012 Jun; 143(6):1307-13. PubMed ID: 22361247
[TBL] [Abstract][Full Text] [Related]
8. The prognostic value of signet ring cell histology in stage I/II colon cancer-a population-based, propensity score-matched analysis.
Ackermann CJ; Guller U; Jochum W; Schmied BM; Warschkow R
Int J Colorectal Dis; 2018 Sep; 33(9):1183-1193. PubMed ID: 29881972
[TBL] [Abstract][Full Text] [Related]
9. Effect of radiation therapy on survival in patients with resected Merkel cell carcinoma: a propensity score surveillance, epidemiology, and end results database analysis.
Kim JA; Choi AH
JAMA Dermatol; 2013 Jul; 149(7):831-8. PubMed ID: 23864085
[TBL] [Abstract][Full Text] [Related]
10. How does autoimmune disease impact treatment and outcomes among patients with lung cancer? A national SEER-Medicare analysis.
Khan SA; Pruitt SL; Xuan L; Makris U; Gerber DE
Lung Cancer; 2018 Jan; 115():97-102. PubMed ID: 29290269
[TBL] [Abstract][Full Text] [Related]
11. Treatment disparities for disabled medicare beneficiaries with stage I non-small cell lung cancer.
Iezzoni LI; Ngo LH; Li D; Roetzheim RG; Drews RE; McCarthy EP
Arch Phys Med Rehabil; 2008 Apr; 89(4):595-601. PubMed ID: 18373987
[TBL] [Abstract][Full Text] [Related]
12. The More the Better-Lower Rate of Stage Migration and Better Survival in Patients With Retrieval of 20 or More Regional Lymph Nodes in Pancreatic Cancer: A Population-Based Propensity Score Matched and Trend SEER Analysis.
Warschkow R; Widmann B; Beutner U; Marti L; Steffen T; Schiesser M; Schmied BM
Pancreas; 2017; 46(5):648-657. PubMed ID: 28196023
[TBL] [Abstract][Full Text] [Related]
13. Healthcare utilization and costs associated with COPD among SEER-Medicare beneficiaries with NSCLC.
Shah S; Blanchette CM; Coyle JC; Kowalkowski M; Arthur ST; Howden R
J Med Econ; 2018 Sep; 21(9):861-868. PubMed ID: 29857784
[TBL] [Abstract][Full Text] [Related]
14. Trends, predictors, and impact of systemic chemotherapy in small cell lung cancer patients between 1985 and 2005.
Behera M; Ragin C; Kim S; Pillai RN; Chen Z; Steuer CE; Saba NF; Belani CP; Khuri FR; Ramalingam SS; Owonikoko TK
Cancer; 2016 Jan; 122(1):50-60. PubMed ID: 26441041
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Segmentectomy and Lobectomy in Stage IA Adenocarcinomas.
Zhao ZR; Situ DR; Lau RWH; Mok TSK; Chen GG; Underwood MJ; Ng CSH
J Thorac Oncol; 2017 May; 12(5):890-896. PubMed ID: 28111235
[TBL] [Abstract][Full Text] [Related]
16. An economic analysis of sublobar resection versus thermal ablation for early-stage non-small-cell lung cancer.
Kwan SW; Mortell KE; Hippe DS; Brunner MC
J Vasc Interv Radiol; 2014 Oct; 25(10):1558-64; quiz 1565. PubMed ID: 25130308
[TBL] [Abstract][Full Text] [Related]
17. Cost of Intensity-modulated Radiation Therapy for Older Patients with Stage III Lung Cancer.
Kale MS; Mhango G; Bonomi M; Federman A; Sigel K; Rosenzweig KE; Wisnivesky JP
Ann Am Thorac Soc; 2016 Sep; 13(9):1593-9. PubMed ID: 27299697
[TBL] [Abstract][Full Text] [Related]
18. Clinical and economic burden associated with stage III to IV triple-negative breast cancer: A SEER-Medicare historical cohort study in elderly women in the United States.
Schwartz KL; Simon MS; Bylsma LC; Ruterbusch JJ; Beebe-Dimmer JL; Schultz NM; Flanders SC; Barlev A; Fryzek JP; Quek RGW
Cancer; 2018 May; 124(10):2104-2114. PubMed ID: 29505670
[TBL] [Abstract][Full Text] [Related]
19. Sublobar resection is equivalent to lobectomy for clinical stage 1A lung cancer in solid nodules.
Altorki NK; Yip R; Hanaoka T; Bauer T; Aye R; Kohman L; Sheppard B; Thurer R; Andaz S; Smith M; Mayfield W; Grannis F; Korst R; Pass H; Straznicka M; Flores R; Henschke CI;
J Thorac Cardiovasc Surg; 2014 Feb; 147(2):754-62; Discussion 762-4. PubMed ID: 24280722
[TBL] [Abstract][Full Text] [Related]
20. Medicare payments from diagnosis to death for elderly cancer patients by stage at diagnosis.
Riley GF; Potosky AL; Lubitz JD; Kessler LG
Med Care; 1995 Aug; 33(8):828-41. PubMed ID: 7637404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]